Interferon γ downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells

Blood

Volumn 90, Issue 6, 1997, Pages 2244-2252

  Taniguchi, Shuichi ^a   Dai, Chun Hua ^a   Price, James O ^a   Krantz, Sanford B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT E; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RNA TRANSCRIPTION;

EID: 0030760131     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2244     Document Type: Article

References (40)

1. Rubin BY, Gupta SL: Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci USA 77:5928, 1980
2. Nakamura M, Manser T, Pearson GDN, Daley MJ, Gefter ML: Effect of IFN-γ on the immune response in vivo and on gene expression in vitro. Nature 307:381, 1984
3. Klimpel GR, Fleischmann WR Jr, Kumpel KD: Gamma Interferon (IFN-γ) and IFNα/β suppress murine myeloid colony formation (CFU-C): Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol 129:76, 1982
4. Zoumbos NC, Djeu JY, Young NS: Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133:769, 1984
5. Means RT Jr, Krantz SB: Inhibition of human erythroid colony-forming units by γ interferon can be corrected by recombinant human erythropoietin. Blood 78:2564, 1991
6. Means RT Jr, Dessypris EN, Krantz SB: Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 150:59, 1992
7. Dai C-H, Krantz SB, Kollar K, Price JO: Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferon γ. J Cell Physiol 165:323, 1995
8. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H: Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 44:186, 1990
9. Fuchs D, Zangerle R, Artner-Dworzak E, Weiss G, Fritsch P, Tilz GP, Dierich MP, Wachter H: Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 50:90, 1993
10. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639, 1992
11. Krantz SB: Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 307:353, 1994
12. Krantz SB: Erythropoietin and the anaemia of chronic disease. Nephrol Dial Transplant 10:10, 1995 (suppl 2)
13. Muta K, Krantz SB: Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 156:264, 1993
14. Muta K, Krantz SB, Bondurant MC, Wickrema A: Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94:34, 1994
15. Pincus T, Olsen NJ, Russell IJ, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB: Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161, 1990
16. de Vos S, Brach MA, Asano Y, Ludwig W-D, Bettelheim P, Gruss H-J, Herrmann F: Transforming growth factor-β1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product. Cancer Res 53:3638, 1993
17. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
18. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
19. low cells in which anti-TGF-β upmodulates c-kit. Blood 86:1729, 1995
20. + cells via p55 TNFα receptors. Blood 84:2506, 1994
21. Harris N, Super M, Ritz M, Chang G, Ezekowitz RAB: Characterization of the murine macrophage mannose receptor: Demonstration that the downregulation of receptor expression mediated by interferon-γ occurs at the level of transcription. Blood 80:2363, 1992
22. Portier M, Zhang X-G, Caron E, Lu Z-Y, Bataille R, Klein B: γ-Interferon in multiple myeloma: Inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. Blood 81:3076, 1993
23. Ruhl S, Feldman GM, Akahane K, Pluznik DH: Interferon-γ antagonizes interleukin-6-induced expression of interleukin-4 receptors in murine myeloid cells by a transcriptional mechanism. Blood 82:2641, 1993
24. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin CI: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 80:357, 1987
25. Sawada K, Krantz SB, Sawyer ST, Civin CI: Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells. J Cell Physiol 137: 337, 1988
26. Cotton EW, Means RT Jr, Cline SM, Krantz SB: Quantitation of insulin-like growth factor-I binding of highly purified human erythroid colony-forming units. Exp Hematol 19:278, 1991
27. Dai C-H, Krantz SB, Koury ST, Kollar K: Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cells. Br J Haematol 88:497, 1994
28. Taniguchi S, Dai C-H, Krantz SB: Specific binding of interferon γ to high affinity receptors on human erythroid colony-forming cells. Exp Hematol 25:193, 1997
29. Wickrema A, Krantz SB, Winkelmann JC, Bondurant MC: Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80:1940, 1992
30. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y: Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503, 1986
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
32. Rosner B: Fundamentals of Biostatistics (ed 2). Boston, MA, PWS, 1986
33. Bagwell B: A journey through flow cytometric immunofluorescence analyses - Finding accurate and robust alogarithms that estimate positive fraction distributions. Clin Immunol Newsletter 16:33, 1996
34. Dai CH, Krantz SB, Zsebo KM: Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 78:2493, 1991
35. McNiece IK, Langley KH, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
36. Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE: Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 78:2216, 1991
37. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PV, Zsebo KM, Adamson JW: Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol 148:503, 1991
38. o and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 89:4013, 1992
39. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R: Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79:634, 1992
40. Selleri C, Maciejewski JP, Sato T, Young NS: Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87:4149, 1996